Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 7/10/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Arthur Sands?

Arthur T. Sands

President

Lexicon Pharmaceuticals Inc

HQ Phone:  (281) 863-3000

Direct Phone: (281) ***-****direct phone

Email: a***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Lexicon Pharmaceuticals Inc

8800 Technology Forest Place

Spring, Texas,77381

United States

Company Description

Lexicon is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for patients with serious, chronic conditions. Through its Genome5000 p...more

Background Information

Employment History

Chief Executive Officer

Nurix , Inc.


Affiliations

Additional

Board Member


Texas Institute for Genomic Medicine

Board Member


Symphony Icon Inc

Board Member


Third Rock Ventures LLC

Chairman of Board of Directors


American Cancer Society Inc

Postdoctoral Fellow In the Department of Human and Molecular Genetics


Education

B.A.

economics and political science

Yale University


M.S.


Ph.D


Ph.D.

Baylor College of Medicine


Web References(161 Total References)


Management Team - Nurix

www.nurix-inc.com [cached]

ARTHUR T. SANDS, M.D., Ph.D.
Chief Executive Officer and Board Director Arthur T. Sands, M.D., Ph.D., serves as the Chief Executive Officer at Nurix and is a member of the company's board of directors. Prior to joining Nurix, Dr. Sands co-founded Lexicon Pharmaceuticals and served as President, Chief Executive Officer and a Director since 1995. At Lexicon, Dr. Sands pioneered the development of large-scale gene knockout technology for use in drug discovery and guided the evolution of Lexicon from a research-stage company to a drug development company, catalyzed by numerous alliances with Bristol Myers Squibb, Takeda and Genentech, and generating more than $450 million in revenue. Dr. Sands serves as Adjunct Professor in the Department of Human and Molecular Genetics at Baylor College of Medicine. He has also published many scientific and medical articles and is an inventor on numerous patents related to the discovery of human genes and their use in the development of new therapies. Dr. Sands holds an M.D. and a Ph.D. from Baylor College of Medicine and a B.A. in economics and political science from Yale University.


www.lexpharma.com

"The development of effective treatments for schizophrenia has been very difficult since the function of most genes related to the disease are not known," stated Arthur T. Sands, M.D., Ph.D., President and CEO of Lexicon Genetics.


www.lexpharma.com

"Lexicon is pleased to have the opportunity to help advance Searles drug discovery efforts," said Arthur T. Sands, M.D., Ph.D., President and Chief Executive Officer of Lexicon Genetics Incorporated.


www.lexpharma.com

Arthur T. Sands, M.D., Ph.D., President and Chief Executive Officer of Lexicon, will present at 9:50 a.m. (Eastern Time) on Thursday, February 21st.
The audio webcast may be accessed on Lexicons corporate website at www.lexicon-genetics.com.


Nurix | Management Team

www.nurix-inc.com [cached]

Arthur T. Sands, M.D., Ph.D.
Chief Executive Officer and Board Director Arthur T. Sands, M.D., Ph.D., serves as the Chief Executive Officer at Nurix and is a member of the company's board of directors. Prior to joining Nurix, Dr. Sands co-founded Lexicon Pharmaceuticals and served as President, Chief Executive Officer and a Director since 1995. At Lexicon, Dr. Sands pioneered the development of large-scale gene knockout technology for use in drug discovery and guided the evolution of Lexicon from a research-stage company to a drug development company, catalyzed by numerous alliances with Bristol Myers Squibb, Takeda and Genentech, and generating more than $450 million in revenue. Dr. Sands serves as Adjunct Professor in the Department of Human and Molecular Genetics at Baylor College of Medicine. He has also published many scientific and medical articles and is an inventor on numerous patents related to the discovery of human genes and their use in the development of new therapies. Dr. Sands holds an M.D. and a Ph.D. from Baylor College of Medicine and a B.A. in economics and political science from Yale University.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory